Europe Approves AstraZeneca COVID-19 Vaccine
Europe Approves AstraZeneca COVID-19 Vaccine
GALWAY, IRELAND--February 8, 2021--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--The European Commission (EC) has approved its third COVID-19 vaccine by granting a conditional marketing authorisation (CMA) for the vaccine developed by AstraZeneca and Oxford University.
Within this article: Details new vaccine permit, delivery issues, efficacy and production capacity
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market
- BMS Investing $400 Million in Dublin Sterile Drug Expansion